Healthcare -
Biotechnology - NASDAQ - US
$ 36.2
-0.958 %
$ 10.3 B
Market Cap
23.35
P/E
EXEL - STOCK-BASED COMPENSATION
Stock-based Compensation EXEL - Exelixis, Inc.
106 M
LAST VALUE
-5.79%
2 YEAR CAGR
19.13%
5 YEAR CAGR
24.35%
10 YEAR CAGR